The drug platform “Stemi RNA” has completed the A round financing of nearly ¥100 million

The drug platform “Stemi RNA” has completed the A round financing of nearly ¥100 million
The drug platform "Stemi RNA" has completed the A round financing of nearly ¥100 million

The drug platform “Stemi RNA” has completed the A round financing of nearly ¥100 million invested by Zhangjiang Torch Venture Capital, Zhuhai Longmen No. 3 Capital, Jiuyo Wisdom, Yitai Jiuyo and Fanghua Investment. This round of financing will be used to build production centers and conduct clinical trials.

Founded in 2016, Stemi RNA focuses on the R&D of innovative mRNA drugs by utilizing the independent intellectual property rights of lipid polymer Nano-carrier technology platform (LPP/mRNA®).

South Africa Today

Read more at VolaNews